Health Economic Models for Relapsing-Remitting Multiple Sclerosis

Mapping Intimacies ◽

10.33612/diss.173519209 ◽

2021 ◽

Author(s):

◽

Luis Gabriel Hernandez

Keyword(s):

Multiple Sclerosis ◽

Health Economic ◽

Economic Models ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Convergence yet Continued Complexity: A Systematic Review and Critique of Health Economic Models of Relapsing-Remitting Multiple Sclerosis in the United Kingdom

Value in Health ◽

10.1016/j.jval.2015.05.006 ◽

2015 ◽

Vol 18 (6) ◽

pp. 925-938 ◽

Author(s):

Felicity Allen ◽

Stephen Montgomery ◽

Maciej Maruszczak ◽

Jeanette Kusel ◽

Nicholas Adlard

Keyword(s):

Multiple Sclerosis ◽

Systematic Review ◽

Health Economic ◽

United Kingdom ◽

Economic Models ◽

The United Kingdom ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Systematic Review and Critique of Health Economic Models on Relapsing-Remitting Multiple Sclerosis in the UK

Value in Health ◽

10.1016/j.jval.2014.08.1780 ◽

2014 ◽

Vol 17 (7) ◽

pp. A548

Author(s):

J. Kusel ◽

M. Maruszczak ◽

S. Montgomery ◽

F. Allen ◽

N. Adlard

Keyword(s):

Multiple Sclerosis ◽

Systematic Review ◽

Health Economic ◽

Economic Models ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

The Uk ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Health Economic Evaluation Of Interferon Beta 1b Versus 1a For Patients Diagnosed With Relapsing Remitting Multiple Sclerosis

Value in Health ◽

10.1016/j.jval.2016.03.223 ◽

2016 ◽

Vol 19 (3) ◽

pp. A69-A70

Author(s):

M Greene ◽

N Greene

Keyword(s):

Multiple Sclerosis ◽

Health Economic ◽

Economic Evaluation ◽

Interferon Beta ◽

Health Economic Evaluation ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

PND38 Optimal Treatment Sequence for Relapsing Remitting Multiple Sclerosis: Results from a Health Economic Modelling Study

Value in Health ◽

10.1016/j.jval.2020.08.1363 ◽

2020 ◽

Vol 23 ◽

pp. S629

Author(s):

M. Versteegh ◽

S. Huygens ◽

B. Wokke ◽

J. Smolders

Keyword(s):

Multiple Sclerosis ◽

Health Economic ◽

Optimal Treatment ◽

Economic Modelling ◽

Treatment Sequence ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis ◽

Health Economic Modelling ◽

Modelling Study

Download Full-text

How To Address French Health Authority (HAS/CEESP) Specific Requirements In Modelling Relapsing-Remitting Multiple Sclerosis In Health-Economic Evaluation? Modelling Treatment Sequences

Value in Health ◽

10.1016/j.jval.2017.08.2107 ◽

2017 ◽

Vol 20 (9) ◽

pp. A752

Author(s):

C Cartier-Bechu ◽

M Sivignon ◽

A Petitjean ◽

S Roze ◽

J Pinguet ◽

...

Keyword(s):

Multiple Sclerosis ◽

Health Economic ◽

Economic Evaluation ◽

Health Authority ◽

Health Economic Evaluation ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis ◽

Treatment Sequences

Download Full-text

A health-economic evaluation of disease-modifying drugs for the treatment of relapsing-remitting multiple sclerosis from the German societal perspective

Clinical Therapeutics ◽

10.1016/j.clinthera.2010.03.019 ◽

2010 ◽

Vol 32 (4) ◽

pp. 717-728 ◽

Author(s):

Mark Nuijten ◽

Thomas Mittendorf

Keyword(s):

Multiple Sclerosis ◽

Health Economic ◽

Economic Evaluation ◽

Societal Perspective ◽

Health Economic Evaluation ◽

Disease Modifying Drugs ◽

Relapsing Remitting ◽

Disease Modifying ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis

Yearbook of Neurology and Neurosurgery ◽

10.1016/j.yneu.2012.04.028 ◽

2012 ◽

Vol 2012 ◽

pp. 70-71

Author(s):

A. Minagar

Keyword(s):

Multiple Sclerosis ◽

Randomized Trial ◽

High Dose ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis ◽

High Dose Vitamin

Download Full-text

Interferon beta-1b therapy in relapsing-remitting multiple sclerosis: Study design and preliminary results

Electroencephalography and Clinical Neurophysiology ◽

10.1016/s0013-4694(97)88414-7 ◽

1997 ◽

Vol 103 (1) ◽

pp. 99

Author(s):

G Salemi

Keyword(s):

Multiple Sclerosis ◽

Study Design ◽

Interferon Beta ◽

Preliminary Results ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Yearbook of Neurology and Neurosurgery ◽

10.1016/s0513-5117(09)79049-0 ◽

2009 ◽

Vol 2009 ◽

pp. 99-103

Author(s):

O. Kantarci

Keyword(s):

Multiple Sclerosis ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

383 Anti GBM Disease in Association with Alemtuzumab Treatment for Relapsing Remitting Multiple Sclerosis: A Rare Presentation of a Rare Disorder

American Journal of Kidney Diseases ◽

10.1053/j.ajkd.2019.03.385 ◽

2019 ◽

Vol 73 (5) ◽

pp. 743-744 ◽

Keyword(s):

Multiple Sclerosis ◽

Rare Disorder ◽

Rare Presentation ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text